XORTX Therapeutics
XRTX2.0600.00% ( 0.000 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: XORTX Therapeutics(XRTX) the EBIT is -680.85 K (+13.93%);the EPS is -0.581 (+37.89%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B13.93%
----
----
EPS
-0.580637.89%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf